A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

Clinical trial NCT03188185 · COMPLETED

Trial details

NCT number: NCT03188185
Sponsor: Alkermes, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2017-06-12
Primary completion: 2020-02-26
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.